HomeInsightsStock Comparison

Amerise Biosciences Ltd vs Bridge Securities Ltd Stock Comparison

Amerise Biosciences Ltd vs Bridge Securities Ltd Stock Comparison

Last Updated on: Oct 22, 2026

Key Highlights

  • The Latest Trading Price of Amerise Biosciences Ltd is ₹ 0.81 as of 22 Oct 15:30 . The P/E Ratio of Amerise Biosciences Ltd changed from 17 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Bridge Securities Ltd changed from 1.1 on March 2021 to 34.3 on March 2026 . This represents a CAGR of 77.41% over 6 years The Market Cap of Amerise Biosciences Ltd changed from ₹ 10.9 crore on March 2021 to ₹ 3.9 crore on March 2026 . This represents a CAGR of -15.74% over 6 yearsThe Market Cap of Bridge Securities Ltd changed from ₹ 1.39 crore on March 2021 to ₹ 53.26 crore on March 2026 . This represents a CAGR of 83.61% over 6 years The revenue of Amerise Biosciences Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bridge Securities Ltd for the Sep '26 is ₹ 0.17 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Amerise Biosciences Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ -0.08 crore. This represent the decline of -100% The ebitda of Bridge Securities Ltd for the Sep '26 is ₹ 0.15 crore as compare to the Jun '26 ebitda of ₹ -0.12 crore. This represent the decline of -225% The net profit of Amerise Biosciences Ltd changed from ₹ -0.05 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Bridge Securities Ltd changed from ₹ 0.03 crore to ₹ 0.14 crore over 10 quarters. This represents a CAGR of 85.18% The Dividend Payout of Amerise Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Bridge Securities Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Amerise Biosciences Ltd

  • Amerise Biosciences Limited was initially incorporated as 'Amstar Laminates Limited' in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment.
  • On October 29, 2002, the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021.
  • Initially, the Company was engaged into the business of commodity trading. During the financial year 2007 it entered into the trading of castor seeds.
  • During the year 2024-25, due to financial crisis Company has not carried out any business activities and faces huge set back.

About Bridge Securities Ltd

  • Bridge Securities Limited was incorporated in December, 1994.
  • Although engaged in various sectors such as Banking, Hospitality Industry or Agro-industry; Teyliom Group has undertaken a partnership with Tunisie Valeurs/ operating on the TUNISIAN financial market, to launch a Management and Intermediation Company (MIC) known as 'Bridge Securities' and was approved by the Regional Council for Public Savings and Capital Markets (CREPMF) in January 2017. The Company is engaged in securities trading, stock broking and leasing.
  • Its mission applies to the Waemu financial market with Capital Markets offer, intended for a clientele looking to optimize their liquid assets through bond securities acquisition or listed shares.
  • Its expertise covers the financial engineering fields by finding appropriate solutions to the financing requirements for company's operation and investment.

FAQs for the comparison of Amerise Biosciences Ltd and Bridge Securities Ltd

Which company has a larger market capitalization, Amerise Biosciences Ltd or Bridge Securities Ltd?

Market cap of Amerise Biosciences Ltd is 5 Cr while Market cap of Bridge Securities Ltd is 27 Cr

What are the key factors driving the stock performance of Amerise Biosciences Ltd and Bridge Securities Ltd?

The stock performance of Amerise Biosciences Ltd and Bridge Securities Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amerise Biosciences Ltd and Bridge Securities Ltd?

As of October 22, 2026, the Amerise Biosciences Ltd stock price is INR ₹0.81. On the other hand, Bridge Securities Ltd stock price is INR ₹6.99.

How do dividend payouts of Amerise Biosciences Ltd and Bridge Securities Ltd compare?

To compare the dividend payouts of Amerise Biosciences Ltd and Bridge Securities Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions